WELL Health Technologies Corp
TSX:WELL

Watchlist Manager
WELL Health Technologies Corp Logo
WELL Health Technologies Corp
TSX:WELL
Watchlist
Price: 5.01 CAD -3.28% Market Closed
Market Cap: 1.2B CAD
Have any thoughts about
WELL Health Technologies Corp?
Write Note
Section:
 

Relative Value

The Relative Value of one WELL stock under the Base Case scenario is 10.78 CAD. Compared to the current market price of 5.01 CAD, WELL Health Technologies Corp is Undervalued by 54%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

WELL Relative Value
Base Case
10.78 CAD
Undervaluation 54%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.3
P/S
P/S
Price to Sales
1.3
vs History
73
vs Industry
59
Median 3Y
1.4
Median 5Y
2.4
Industry
2.4
Forward
1.2
More Details
17
P/E
P/E
Price to Earnings
17
vs History
14
vs Industry
12
Median 3Y
-21.2
Median 5Y
-24.3
Industry
23.2
Forward
10.2
More Details
9.9
P/OCF
P/OCF
Price to OCF
9.9
vs History
60
vs Industry
23
Median 3Y
13.9
Median 5Y
12.7
Industry
14.9
More Details
28.3
P/FCFE
P/FCFE
Price to FCFE
28.3
vs History
33
vs Industry
27
Median 3Y
12.8
Median 5Y
15.2
Industry
20.6
More Details
1.5
P/B
P/B
Price to Book Value
1.5
vs History
57
vs Industry
53
Median 3Y
1.3
Median 5Y
1.6
Industry
2.2
More Details
1.6
EV/S
EV/S
Enterprise Value to Sales
1.6
vs History
82
vs Industry
52
Median 3Y
2
Median 5Y
3.1
Industry
2.5
Forward
1.5
More Details
3.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.7
vs History
66
vs Industry
52
Median 3Y
3.8
Median 5Y
5.8
Industry
5.1
More Details
14
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
14
vs History
38
vs Industry
22
Median 3Y
15.1
Median 5Y
13.1
Industry
12.9
Forward
11.9
More Details
36
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
36
vs History
39
vs Industry
8
Median 3Y
42.3
Median 5Y
32.5
Industry
17.4
Forward
28.4
More Details
12.3
EV/OCF
EV/OCF
Enterprise Value to OCF
12.3
vs History
60
vs Industry
18
Median 3Y
18.5
Median 5Y
17.2
Industry
14.6
More Details
13.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
13.6
vs History
60
vs Industry
19
Median 3Y
20.7
Median 5Y
19.4
Industry
18.4
More Details
1.1
EV/IC
EV/IC
Enterprise Value to IC
1.1
vs History
55
vs Industry
55
Median 3Y
1
Median 5Y
1.2
Industry
1.9
More Details

Multiples Across Competitors

WELL Competitors Multiples
WELL Health Technologies Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
WELL Health Technologies Corp
TSX:WELL
1.2B CAD 1.3 17 14 36
US
Cigna Group
XMUN:CGN
88.5B EUR 0.4 30.8 9.2 11.9
US
Cigna Corp
NYSE:CI
90.7B USD 0.4 29.8 9 11.6
US
CVS Health Corp
NYSE:CVS
68.1B USD 0.2 13.6 10.7 10.7
DE
Fresenius Medical Care AG
XMUN:FME
24B EUR 1.2 45.2 10.6 24.4
US
Laboratory Corporation of America Holdings
NYSE:LH
20.1B USD 1.6 46.1 13.7 21.1
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.6B EUR 0.8 -16.6 14.4 22.3
US
Quest Diagnostics Inc
NYSE:DGX
17.6B USD 1.8 21 12.6 17
US
DaVita Inc
NYSE:DVA
13B USD 1 15.7 8 11.2
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
12B EUR 0.6 22.5 6.8 15.6
US
Chemed Corp
NYSE:CHE
8.5B USD 3.6 28 17.8 20.6

See Also

Summary
WELL intrinsic value, competitors valuation, and company profile.
DCF Valuation
WELL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
WELL stock valuation using valuation multiples.
Wall Street Estimates
WELL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
WELL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 198,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.